Samsung Medical Center
π°π·South Korea
- Country
- π°π·South Korea
- Ownership
- Subsidiary
- Established
- 1994-01-01
- Employees
- 501
- Market Cap
- -
Comparison of Dexmedetomidine and Remifentanil Infusion During CABG
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-06
- Last Posted Date
- 2013-12-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 77
- Registration Number
- NCT01572454
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Hemostasis in Patients With Idiopathic Thrombocytopenic Purpura
Completed
- Conditions
- First Posted Date
- 2012-04-05
- Last Posted Date
- 2013-12-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT01571349
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Therapeutic Efficacy and Safety of Palonosetron in Treatment of Postoperative Nausea and Vomiting
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-02
- Last Posted Date
- 2013-12-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 384
- Registration Number
- NCT01568268
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
π°π·Bungdang Seoul National University Hospital, Seoul, Korea, Republic of
π°π·Kangpook Samsung Hospital, Seoul, Korea, Republic of
Graft Patency Analysis of the Right Coronary Artery System
Terminated
- Conditions
- Interventions
- First Posted Date
- 2012-03-21
- Last Posted Date
- 2019-04-05
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 50
- Registration Number
- NCT01559350
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
Umbilical Cord Blood-derived Mesenchymal Stem Cells for the Treatment of Steroid-refractory Acute or Chronic Graft-versus-host-disease
- First Posted Date
- 2012-03-09
- Last Posted Date
- 2012-03-16
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 30
- Registration Number
- NCT01549665
- Locations
- π°π·
Department of Pediatrics, Samsung Medical Center, Seoul, Korea, Republic of
The Effect of a Probiotic Preparation (VSL#3) Plus Infliximab in Children With Crohn's Disease
Phase 3
- Conditions
- First Posted Date
- 2012-03-08
- Last Posted Date
- 2012-03-08
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 1
- Registration Number
- NCT01548014
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing One-lung Ventilation for Lung Surgery
Not Applicable
Completed
- Conditions
- First Posted Date
- 2012-02-28
- Last Posted Date
- 2013-12-25
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 110
- Registration Number
- NCT01540201
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
pazopanib_NCRCC,Ph2 STUDY
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-02-24
- Last Posted Date
- 2017-04-26
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 10
- Registration Number
- NCT01538238
- Locations
- π°π·
Samsung medical Center, Seoul, Korea, Republic of
Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease
Phase 2
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2012-02-08
- Last Posted Date
- 2012-12-17
- Lead Sponsor
- Samsung Medical Center
- Registration Number
- NCT01528930
- Locations
- π°π·
Samsung Medical Center, Seoul, Korea, Republic of
LOXL1 Polymorphism in Pseudoexfoliation Syndrome
- Conditions
- First Posted Date
- 2012-01-24
- Last Posted Date
- 2012-01-24
- Lead Sponsor
- Samsung Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT01515735
- Locations
- π°π·
Samsung medical center, Seoul, Korea, Republic of
Β© Copyright 2024. All Rights Reserved by MedPath